DKS Q4 earnings didn’t just beat estimates-they rewrote expectations, delivering $1.13/share (a penny above guidance) on top of 20% year-over-year sales growth. This wasn’t just a quarterly win; it was a strategic inflection point, where legacy hardware met emerging demand with surgical precision. I’ve seen too many companies chase trends only to stumble when the […]